MannKind Corporation (MNKD) Social Stream
MANNKIND CORP (MNKD) Price Targets From Analysts
Use the tables below to see what analysts covering MANNKIND CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 3 | $6.5 | $5 | $5.8 | $3.47 | 67.15% |
| 2022-02-25 | 5 | $6.5 | $5 | $5.9 | $3.47 | 70.03% |
| 2022-05-06 | 5 | $6.5 | $5 | $5.6 | $3.47 | 61.38% |
| 2022-08-12 | 3 | $6.5 | $5 | $5.75 | $3.47 | 65.71% |
| 2022-11-09 | 4 | $6.5 | $5 | $5.75 | $3.47 | 65.71% |
| 2023-02-08 | 4 | $6.5 | $5.5 | $6 | $3.47 | 72.91% |
| 2023-02-24 | 4 | $7 | $5.5 | $6.25 | $3.47 | 80.12% |
| 2023-02-27 | 4 | $7 | $5.5 | $6.5 | $3.47 | 87.32% |
| 2023-05-11 | 4 | $7 | $6.5 | $6.833 | $3.47 | 96.92% |
| 2023-08-07 | 4 | $7 | $6.5 | $6.75 | $3.47 | 94.52% |
| 2023-08-08 | 4 | $7.5 | $6.5 | $7 | $3.47 | 101.73% |
| 2023-08-14 | 4 | $7.5 | $6.5 | $7.125 | $3.47 | 105.33% |
| 2023-11-08 | 5 | $10 | $6.5 | $7.7 | $3.47 | 121.9% |
| 2023-11-13 | 5 | $10 | $5.5 | $7.3 | $3.47 | 110.37% |
The Trend in the Analyst Price Target
Over the past 32 months, MNKD's average price target has gone up $0.7.
MNKD reports an average of 56.72% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-27 | 4 | 7 | 6.5 | 6.750 | 4.03 | 67.49% |
| 2023-05-11 | 4 | 7 | 6.5 | 6.833 | 4.24 | 61.16% |
| 2023-07-10 | 4 | 7 | 6.5 | 6.750 | 4.12 | 63.83% |
| 2023-07-11 | 4 | 7 | 6.5 | 6.750 | 4.09 | 65.04% |
| 2023-08-07 | 4 | 7 | 6.5 | 6.750 | 4.60 | 46.74% |
MNKD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
MNKD's average broker recommendation rating improved by 0.4 over the prior 19 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, MANNKIND CORP's average analyst price target is greater than 96.61% of them.
- In terms of how MANNKIND CORP fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 221.56% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MANNKIND CORP's variance in analysts' estimates is lower than -130.14% of them.
- In the context of stocks in the mid market cap category, MANNKIND CORP's upside potential (average analyst target price relative to current price) is higher than 1200.63% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MANNKIND CORP are AMRN, LGND, and ARWR.
View All Top Stocks by Price Target
What is the outlook for MNKD? Use POWR Ratings for clearer insight into price direction.